N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy
Open Access
- 21 August 2022
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 151, 588-599
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20202002)
- National Key Research and Development Program of China (2018YFA0901700)
- Fundamental Research Funds for the Central Universities (JUSRP51712B)
- National Natural Science Foundation of China National Outstanding Youth Science Fund Project (31700706)
- Hubei University of Medicine (2021QDJZR015)
- Sun Yat-sen University (2018008)
- National Natural Science Foundation of China
This publication has 41 references indexed in Scilit:
- Fluorogenic Probing of Specific Recognitions between Sugar Ligands and Glycoprotein Receptors on Cancer Cells by an Economic Graphene NanocompositeAdvanced Materials, 2013
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species ProductionIn VitroandIn VivoMolecular Cancer Therapeutics, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5Cancer Research, 2006
- VEGF as a Key Mediator of Angiogenesis in CancerOncology, 2005
- Clinical features of hepatocellular carcinoma with extrahepatic metastasesJournal of Gastroenterology and Hepatology, 2005
- Temporal targeting of tumour cells and neovasculature with a nanoscale delivery systemNature, 2005
- Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolizationLiver Transplantation, 2004
- A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policyLiver Transplantation, 2003
- Hepatic Binding Protein: The Galactose-Specific Receptor of Mammalian HepatocytesHepatology, 1983